Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Rigel's Drug Trials Offer Upside Through 2013
Seeking Alpha
Tue, 07/31/12 - 07:09 pm
Tags:
Rigel Pharmaceuticals, Abbott Labs, Amgen, AstraZeneca
Roche Building On Its Strengths
Seeking Alpha
Mon, 07/30/12 - 11:44 am
Tags:
Roche, Abbott Labs, AstraZeneca, Gilead, Complete Genomics, Sanofi, Pfizer, Pacific Biosciences, JNJ, Novartis, Illumina, GSK
Generics knock AstraZeneca Q2 earnings by 24 pct
Yahoo/AP
Thu, 07/26/12 - 09:24 am
Tags:
earnings, AstraZeneca
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
Tags:
drug approvals, earnings, Amylin, InterMune, Human Genome Sciences, GSK, Bristol-Myers Squibb, Questcor, BiogenIdec, Alexion, Regeneron, Eli Lilly, Amarin, Horizon Pharma, Celgene, Amgen, Gilead, Alkermes, United Therapeutics, Roche, Sanofi, Merck, AstraZeneca, Salix, Progenics Pharmaceuticals
AstraZeneca backs $12M round for upstart's self-assembling drug pipeline
Fierce Biotech
Wed, 07/18/12 - 12:59 pm
Tags:
AstraZeneca, MedImmune Ventures, Ascent Biomedical Ventures
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Tags:
Pluristem Therapeutics, Alkermes, AstraZeneca, Bristol-Myers Squibb, Isis Pharmaceuticals, Eli Lilly, Momenta, Merck, Pfizer, Sanofi, Spectrum Pharmaceuticals
AstraZeneca Expands Study Of Brilinta Against Plavix
Bloomberg
Tue, 07/17/12 - 10:47 am
Tags:
AstraZeneca, Plavix, Brilinta, bloodthinners
Ex-AstraZeneca chief forfeits up to £3.5M in exit pay
Fierce Pharma
Mon, 07/16/12 - 07:36 pm
Tags:
executive pay, AstraZeneca, David Brennan
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Fri, 07/13/12 - 01:23 pm
Tags:
GSK, Amylin, AstraZeneca, Merck, Novartis, Pfizer
The Challenges in Staying #1 in Big Pharma
Forbes
Fri, 07/13/12 - 01:22 pm
Tags:
Merck, Novartis, Pfizer, AstraZeneca
AstraZeneca acquires neuroscience assets from Link Medicine
Yahoo/Fly on the Wall
Thu, 07/12/12 - 12:34 pm
Tags:
Link Medicine, AstraZeneca, M&A
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:12 pm
Tags:
Xenon, Virobay, Tolero Pharmaceuticals, Threshold Pharmaceuticals, Novartis, Merck KGaA, Merck, MannKind, licensing, Janssen, Isis Pharmaceuticals, Ironwood, Inhibrx Thrombogenics, GSK, Genmab, Genentech, Galapagos, Forma Therapeutics, Endocyte, Endo, Enanta, Celgene, Bristol-Myers Squibb, Boehringer Ingelheim, Bionomics, Biogen Idec, BioDelivery Sciences, AstraZeneca, Angiochem, AC Immune, Abbott Laboratories, LEO Pharma
Novartis: Buy Before The Bullish Rally
Seeking Alpha
Mon, 07/9/12 - 10:40 am
Tags:
Novartis, Pfizer, JNJ, AstraZeneca
Amylin Deal Signals Diabetes Space is Hot
Motley Fool
Fri, 07/6/12 - 07:34 pm
Tags:
diabetes, Amylin, M&A, Bristol-Myers Squibb, AstraZeneca
Seven pharma companies partner with Gates Foundation to speed TB drug discovery
Yahoo/Fly on the Wall
Fri, 07/6/12 - 12:45 pm
Tags:
tuberculosis, Bill Gates, Abbott Laboratories, AstraZeneca, Bayer, Eli Lilly, GSK, Merck, Sanofi
Big Pharma’s Big Fines
ProPublica.org
Thu, 07/5/12 - 05:16 pm
Tags:
fines, whistleblower lawsuits, Eli Lilly, Pfizer, AstraZeneca, Merck, Abbott Laboratories, GSK
Expert On The Amylin Purchase: 'I Hate This Deal'
Forbes
Tue, 07/3/12 - 01:07 pm
Tags:
Amylin, Bristol-Myers Squibb, M&A, AstraZeneca
Today's Bio Pharma Buyout News And Watch List
Seeking Alpha
Tue, 07/3/12 - 11:38 am
Tags:
Amylin, AstraZeneca, Obagi Medical Products, Eli Lilly, GSK, Bristol-Myers Squibb
AstraZeneca hungry to refill medicine cabinet
Yahoo/Reuters
Sat, 06/30/12 - 03:55 pm
Tags:
AstraZeneca
Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb’s Acquisition of Amylin Pharmaceuticals
Yahoo/BusinessWire
Sat, 06/30/12 - 03:28 pm
Tags:
Bristol-Myers Squibb, AstraZeneca, Amylin, M&A, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.